Seborrheic Dermatitis Treatment Market Research Report - Forecast till 2027

Seborrheic Dermatitis Treatment Market Research Report: By Treatment Type (Antifungal Products, Corticosteroid Lotions, Sulfur Products), Route of Administration (Oral, Topical) and End-User (Hospital Pharmacies, Retail Pharmacies, Others) – Forecast to 2027

ID: MRFR/HC/7027-HCR | February, 2021 | Region : Global

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE

6.1. Overview

6.2. Antifungal Product

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Corticosteroid Lotions

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Sulfur Products

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

7.1. Overview

7.2. Oral

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Topical

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER

8.1. Overview

8.2. Hospital Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Retail Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

11. COMPANY PROFILES

11.1. Sonoma Pharmaceuticals

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Key Developments

11.1.4. SWOT Analysis

11.1.5. Key Strategies

11.2. Merck

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Key Developments

11.2.4. SWOT Analysis

11.2.5. Key Strategies

11.3. Hikma Pharmaceuticals

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Key Developments

11.3.4. SWOT Analysis

11.3.5. Key Strategies

11.4. Allen and Hanburys

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Key Developments

11.4.4. SWOT Analysis

11.4.5. Key Strategies

11.5. GlaxoSmithKline

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Key Developments

11.5.4. SWOT Analysis

11.5.5. Key Strategies

11.6. Bausch Health

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Key Developments

11.6.4. SWOT Analysis

11.6.5. Key Strategies

11.7. Valent Pharmaceutical

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Key Developments

11.7.4. SWOT Analysis

11.7.5. Key Strategies

11.8. West-Ward Pharmaceutical Corp.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Key Developments

11.8.4. SWOT Analysis

11.8.5. Key Strategies

11.9. Others

12. APPENDIX

12.1. References

12.2. Related Reports 

LIST OF TABLES

TABLE 1 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 12 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 13 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 15 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET

FIGURE 4 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY TREATMENT TYPE, 2020 (%)

FIGURE 5 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)

FIGURE 6 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 SONOMA PHARMACEUTICALS.: KEY FINANCIALS

FIGURE 16 SONOMA PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 17 SONOMA PHARMACEUTICALS: REGIONAL REVENUE

FIGURE 18 MERCK: KEY FINANCIALS

FIGURE 19 MERCK: SEGMENTAL REVENUE

FIGURE 20 MERCK: REGIONAL REVENUE

FIGURE 21 HIKMA PHARMACEUTICALS: KEY FINANCIALS

FIGURE 22 HIKMA PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 23 HIKMA PHARMACEUTICALS: REGIONAL REVENUE

FIGURE 24 ALLEN AND HANBURYS: KEY FINANCIALS

FIGURE 25 ALLEN AND HANBURYS: SEGMENTAL REVENUE

FIGURE 26 ALLEN AND HANBURYS: REGIONAL REVENUE

FIGURE 27 GLAXOSMITHKLINE: KEY FINANCIALS

FIGURE 28 GLAXOSMITHKLINE: SEGMENTAL REVENUE

FIGURE 29 GLAXOSMITHKLINE: REGIONAL REVENUE

FIGURE 30 BAUSCH HEALTH: KEY FINANCIALS

FIGURE 31 BAUSCH HEALTH: SEGMENTAL REVENUE

FIGURE 32 BAUSCH HEALTH: REGIONAL REVENUE

FIGURE 33 VALENT PHARMACEUTICAL: KEY FINANCIALS

FIGURE 34 VALENT PHARMACEUTICAL: SEGMENTAL REVENUE

FIGURE 35 VALENT PHARMACEUTICAL: REGIONAL REVENUE

FIGURE 36 WEST-WARD PHARMACEUTICAL CORP: KEY FINANCIALS

FIGURE 37 WEST-WARD PHARMACEUTICAL CORP: SEGMENTAL REVENUE

FIGURE 38 WEST-WARD PHARMACEUTICAL CORP: REGIONAL REVENUE




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Seborrheic Dermatitis Treatment Market